Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > I Wonder..

<< Previous

Bullboard Posts

Next >>

Post by Kingpin68on Aug 12, 2024 9:57am

505 Views

Post# 36174285

I Wonder..

Why is the number of evaluated patients at 450 days now at 41 (18 out of 41). At the last quarter update it was 59 (19 out of 59). Seems they are now only counting patients who received a CR at any point in time. I assume this new parameter is in line with how other studies are done ? They really haven't explained why the change.
The timeline to submit both pre btd and BTD in 3rd quarter is positive.

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles